Skip to search boxSkip to navigationSkip to main content

4D flow MRI quantification of mitral and tricuspid regurgitation: Reproducibility and consistency relative to conventional MRI

  • Jennifer F. Feneis
    ,
  • Espoir Kyubwa
    ,
  • Kimberly Atianzar
    ,
  • Joseph Y. Cheng
    ,
  • Marcus T. Alley
    ,
  • Shreyas S. Vasanawala
*Corresponding author for this work
  • University of California at San Diego
    ,
  • Swedish Heart and Vascular Institute
    ,
  • Department of Radiology
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

Background: In patients with mitral or tricuspid valve regurgitation, evaluation of regurgitant severity is essential for determining the need for surgery. While transthoracic echocardiography is widely accessible, it has limited reproducibility for grading inlet valve regurgitation. Multiplanar cardiac MRI is the quantitative standard but requires specialized local expertise, and is thus not widely available. Volumetric 4D flow MRI has potential for quantitatively grading the severity of inlet valve regurgitation in adult patients. Purpose: To evaluate the accuracy and reproducibility of volumetric 4D flow MRI for quantification of inlet valvular regurgitation compared to conventional multiplanar MRI, which may simplify and improve accessibility of cardiac MRI. Study Type: This retrospective, HIPAA-compliant imaging-based comparison study was conducted at a single institution. Subjects: Twenty-one patients who underwent concurrent multiplanar and 4D flow cardiac MRI between April 2015 and January 2017. Field Strength/Sequences: 3T; steady-state free-precession (SSFP), 2D phase contrast (2D-PC), and postcontrast 4D flow. Assessment: We evaluated the intertechnique (4D flow vs. 2D-PC), intermethod (direct vs. indirect measurement), interobserver and intraobserver reproducibility of measurements of regurgitant flow volume (RFV), fraction (RF), and volume (RVol). Statistical Tests: Statistical analysis included Pearson correlation, Bland–Altman statistics, and intraclass correlation coefficients. Results: There was high concordance between 4D flow and multiplanar MRI, whether using direct or indirect methods of quantifying regurgitation (r = 0.813–0.985). Direct interrogation of the regurgitant jet with 4D flow showed high intraobserver consistency (r = 0.976–0.999) and interobserver consistency (r = 0.861–0.992), and correlated well with traditional indirect measurements obtained as the difference between stroke volume and forward outlet valve flow. Data Conclusion: 4D flow MRI provides highly reproducible measurements of mitral and tricuspid regurgitant volume, and may be used in place of conventional multiplanar MRI. Level of Evidence: 4. Technical Efficacy: Stage 2. J. Magn. Reson. Imaging 2018;48:1147–1158.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1147-1158 (12 pages)

Journal (Volume, Issue Number)

Journal of Magnetic Resonance Imaging (Volume 48, Issue 4)

Publication milestones

  • Published - 10/2018

Publication status

Published - 10/2018

ISSN

1053-1807

Publication IDs

  • Scopus: 85051297246
  • PubMed: 29638024

Publication metrics

Metrics

Scopus
citations
SciVal
citations
28
SciVal
FWCI
3.96
SciVal
Author count
8
SciVal
Paper percentile
95
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
96
Citation count
97

Funding Details

E. Kyubwa is supported by the Howard Hughes Medical Institute Gilliam Fellowship and the University of California, San Diego Medical Scientist Training Program T32 GM007198-40. M.T. Alley discloses research funding from General Electric and is a consultant to Arterys Inc. S.S. Vasanawala is involved with research collaboration with General Electric, is a founder and consultant to Arterys Inc, and has a research grant from Bayer AG. A. Hsiao is founder and consultant to Arterys, Inc, and has a research grant from GE Healthcare.
FundersFunding numbers
Arterys Inc.
-
University of California, San Diego Medical Scientist Training Program
T32 GM007198-40
HHMI
-
NIGMS
T32GM007198
GE
-
GE Healthcare and Phillips Healthcare
-